Literature DB >> 22585213

An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China.

Yong Wang1, Shaofu Qiu, Guang Yang, Lixue Song, Wenli Su, Yuanyong Xu, Leili Jia, Ligui Wang, Rongzhang Hao, Chuanfu Zhang, Jingmei Liu, Xiuping Fu, Jinrong He, Jingshan Zhang, Zhenjun Li, Hongbin Song.   

Abstract

Eighteen out of 45 children were reported to have a respiratory illness during an outbreak at a temporary dormitory in a nursery school in China in 2011. To study the outbreak and to determine the risk factors for infection, an epidemiological investigation was performed. A standardized questionnaire was completed for a total of 45 children with the help of their guardians and parents. In addition, acute- and convalescent-phase serum samples and throat swabs from the children were taken for laboratory diagnosis. The diagnosis of a Mycoplasma-like illness was based on the following clinical criteria. The criteria were onset of illness after 31 May 2011, characterized by a cough, fever(>37.5 °C), or at least 3 of the following symptoms: fever, sore throat, cough or expectoration, and runny or stuffy nose. PCR-restriction fragment length polymorphism (PCR-RFLP), determination of MICs, and sequencing were performed to determine the genotype, antibiotic resistance, and sequence polymorphisms of the isolated strains, respectively. The paired sera revealed that 15 patients were infected with Mycoplasma pneumoniae. Epidemiology confirmed that this was a point source outbreak, characterized by a short incubation period, a high secondary attack rate, and a long period of hospitalization. PCR-RFLP analysis revealed that the 12 isolated strains of M. pneumoniae shared the same subtype P1 gene, and 23S rRNA sequence analysis showed that these strains harbored two macrolide-resistant gene-related point mutations at position 2063 and 2617. In this outbreak, the major risk factor was the distance between the bed of the first patient and the beds of close contacts (beds less than three meters apart). The strains isolated in this study were found to harbor two point mutations conferring macrolide resistance, indicating the importance of pathogen and drug resistance surveillance systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585213      PMCID: PMC3393466          DOI: 10.1128/AAC.00142-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial.

Authors:  L Roberts; W Smith; L Jorm; M Patel; R M Douglas; C McGilchrist
Journal:  Pediatrics       Date:  2000-04       Impact factor: 7.124

2.  Mycoplasma pneumoniae infection in families.

Authors:  N Balassanian; F C Robbins
Journal:  N Engl J Med       Date:  1967-10-05       Impact factor: 91.245

3.  Mycoplasma pneumoniae in the community.

Authors:  H M Foy; G E Kenny; R McMahan; G Kaiser; J T Grayston
Journal:  Am J Epidemiol       Date:  1971-01       Impact factor: 4.897

4.  Outbreaks of Mycoplasma pneumoniae respiratory infection--Ohio, Texas, and New York, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-12-10       Impact factor: 17.586

5.  Epidemiology of Mycoplasma pneumoniae infection in families.

Authors:  H M Foy; J T Grayston; G E Kenny; E R Alexander; R McMahan
Journal:  JAMA       Date:  1966-09-12       Impact factor: 56.272

Review 6.  Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients.

Authors:  H M Foy
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

7.  [An outbreak of mycoplasma pneumoniae pneumonia in a kindergarten].

Authors:  Chun-ling Liu; Jin-gui Cao; Ping Zhou; Hua Xu; Shu-guo Ji; Yan-bo Li; Jun-hong Zhang; Xiao-yu Liu; Chun-qian Zheng
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2009-03

8.  Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera.

Authors:  H W Wilkinson; D D Cruce; C V Broome
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

9.  Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Authors:  T S Lucier; K Heitzman; S K Liu; P C Hu
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Mycoplasma pneumoniae infection in Hong Kong--clinical and epidemiological features during an epidemic.

Authors:  H S Hosker; J S Tam; C H Chain; C K Lai
Journal:  Respiration       Date:  1993       Impact factor: 3.580

View more
  8 in total

1.  Study of Two Separate Types of Macrolide-Resistant Mycoplasma pneumoniae Outbreaks.

Authors:  Yingshuo Wang; Qian Ye; Dehua Yang; Zhimin Ni; Zhimin Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

5.  Cluster of macrolide-resistant Mycoplasma pneumoniae infections in Illinois in 2012.

Authors:  Victoria Tsai; Bernard B Pritzker; Maureen H Diaz; Jonas M Winchell; Lauri A Hicks; Brianna Petrone; Alvaro Benitez; Bernard J Wolff; Kenneth L Soyemi
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

6.  Comparison of pyrosequencing, Sanger sequencing, and melting curve analysis for detection of low-frequency macrolide-resistant mycoplasma pneumoniae quasispecies in respiratory specimens.

Authors:  Kwok-Hung Chan; Kelvin K W To; Betsy W K Chan; Clara P Y Li; Susan S Chiu; Kwok-Yung Yuen; Pak-Leung Ho
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

Review 7.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

8.  Outbreak of macrolide-resistant mycoplasma pneumoniae in a primary school in Beijing, China in 2018.

Authors:  Wen-Zeng Zhang; Song-Jian Zhang; Quan-Yi Wang; Yin-Dong Li; Hong-Bo Jing; Guang-Yi Hu; Dan Wu
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.